Biosimilars: More Treatment Options Are on the Way

The Food and Drug Administration (FDA) is approving Zarxio (filgrastim-sndz), the first biosimilar product (or biosimilar), and expects to approve others in the months ahead. What are biosimilars? How will they affect patient treatment?
FDA Consumer Health Information Updates

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us